GAMMA Investing’s Axonics, Inc. Common Stock AXNX Stock Holding History

GAMMA Investing’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21	Closed	-$1.46K	–	3846
2024 Q3	$1.46K	Hold	21	–	–	﹤0.01%	3155
2024 Q2	$1.41K	Hold	21	–	–	﹤0.01%	2977
2024 Q1	$1.45K	Buy	21 +9	+75%	+$607	﹤0.01%	2849
2023 Q4	$815	Buy	+12	New	+$671	﹤0.01%	2847

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

GAMMA Investing's AXNX Position: Q4 2024 in Review

GAMMA Investing sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 21 shares — an estimated $1.46K sold.

GAMMA Investing first reported a position in AXNX in Q4 2023 and held it in 4 quarters. The position peaked at $1.46K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

GAMMA Investing reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
GAMMA Investing sold 21 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.46K.
GAMMA Investing first reported a position in Axonics, Inc. Common Stock in Q4 2023 and held it in 4 quarters.
GAMMA Investing's Axonics, Inc. Common Stock position peaked at $1.46K in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.